Status | Study |
RECRUITING |
Study Name: Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Condition: Graft vs Host Disease Date: 2022-09-03 Interventions: Pacritinib will be given as 100 mg or 200 mg tablets to be taken orally twice daily (12 hours apart) on days 1-28 of a 28 day cycle.Morning and |
Recruiting |
Study Name: Topical Vitamin D in Acute Graft Versus Host Disease of the Skin Condition: Graft Vs Host Disease Date: 2017-03-23 Interventions: Dietary Supplement: Calcipotriene Topical vitamin D cream will be applied to affected areas of the skin. |
Recruiting |
Study Name: A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease Condition: Graft vs Host Disease Date: 2016-07-20 Interventions: Drug: KD025 Other Name: SLx-2119 |
Not yet recruiting |
Study Name: Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease Condition: Graft vs Host Disease Date: 2015-06-15 Interventions: Drug: Cannabidiol |
Recruiting |
Study Name: A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease Condition: Graft vs Host Disease Date: 2015-03-01 Interventions: Biological: Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease |
Recruiting |
Study Name: Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study Condition: Graft vs Host Disease Date: 2014-06-17 Interventions: Biological: Decidual Stromal Cells thawed in plasma |
Not yet recruiting |
Study Name: A Phase 2 Study Using Placenta Derived Decidual Stromal Cells for Graft Versus Host Disease Condition: Graft vs Host Disease Date: 2014-06-17 Interventions: Biological: Early Decidual stromal cell therapy |
Terminated |
Study Name: A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients Condition: Graft vs Host Disease Date: 2013-10-23 Interventions: Drug: ASEDs Experimental Inter |
Completed |
Study Name: Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease Condition: Graft vs Host Disease Date: 2012-11-25 Interventions: Drug: Tacrolimus D-1~D20: iv i |
Active, not recruiting |
Study Name: A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease Condition: Graft vs Host Disease Date: 2012-10-02 Interventions: Drug: Alpha-1-Antitrypsin (AAT) AAT (Zemaira) will be administered at a dose of 60mg/kg (actual weight) |